Department of Nephrology, Hospital Juárez deMéxico, Mexico City, Mexico,
Department of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico,
Blood Purif. 2024;53(2):130-137. doi: 10.1159/000534823. Epub 2023 Oct 27.
The ideal modality choice and dialysis prescription during the first renal replacement therapy (RRT) session remain unclear. We conducted a pilot study to determine the safety risk for hemodialysis (HD) versus hemofiltration (HF) and its relationship with neurocognitive assessment on incident RRT patients.
Twenty-four incident RRT patients were included. Patients were randomized to the conventional HD group or post-dilution HF group. Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MOCA) tests were applied in all patients before and after session, and brain magnetic resonance image (MRI) was performed in 7 patients from the conventional HD group and 8 patients from the post-dilution HF group before and after the intervention.
Baseline characteristics were similar between groups. Compared to conventional HD, post-dilution HF had longer treatment time. There were no significant changes in blood pressure after RRT in both groups. The MMSE test showed no significant differences between groups or within groups. The MOCA test showed an increase in the total score for the post-dilution HF group with no significant changes between groups. The MRI evaluation showed no differences between or within groups.
Post-dilution HF is a safe alternative for the first HD session in incident RRT; it allows longer treatment time if ultrafiltration is required and has a similar neurological risk than conventional HD. This is a pilot study and that larger studies are needed to confirm the findings.
首次肾脏替代治疗 (RRT) 期间的理想治疗方式选择和透析方案仍不明确。我们进行了一项试点研究,以确定血液透析 (HD) 与血液滤过 (HF) 的安全性风险及其与新发 RRT 患者神经认知评估的关系。
纳入 24 例新发 RRT 患者。患者随机分为常规 HD 组或后稀释 HF 组。所有患者在治疗前后均进行简易精神状态检查 (MMSE) 和蒙特利尔认知评估 (MOCA) 测试,常规 HD 组 7 例和后稀释 HF 组 8 例患者在干预前后均进行脑磁共振成像 (MRI) 检查。
两组患者的基线特征相似。与常规 HD 相比,后稀释 HF 的治疗时间更长。两组患者 RRT 后血压均无明显变化。MMSE 测试显示两组间或组内均无显著差异。MOCA 测试显示后稀释 HF 组的总分增加,但两组间无显著差异。MRI 评估显示两组间或组内均无差异。
后稀释 HF 是新发 RRT 首次 HD 治疗的安全替代方法;如果需要超滤,它可以提供更长的治疗时间,并且与常规 HD 的神经风险相似。这是一项试点研究,需要更大规模的研究来证实这些发现。